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Abstract
The frequent human pathogen Staphylococcus aureus requires a sufficient 
source of iron to proliferate and, thus, to sustain an infection of a mammalian host. 
However, the free iron concentration in the host is insufficient for bacterial growth 
without use of specialized uptake mechanisms. To overcome this, S. aureus utilizes 
multiple systems to scavenge host iron. One such strategy that S. aureus employs is the 
use of siderophores: secreted, small-molecular-weight, high-affinity iron chelators. S. 
aureus synthesizes and secretes two anionic a-hydroxycarboxylate siderophores, 
staphyloferrin A (SA) and staphyloferrin B (SB). Fe-SA and Fe-SB complexes are 
transported into the cell through the highly specific ABC-type transporters HtsABC and 
SirABC, respectively. The crystal structures of HtsA, the SA receptor, have been solved 
for both SA bound and unbound forms. Structural data indicate that HtsA has a unique 
positively charged binding pocket and many charged residues form contacts with the 
anionic siderophore including R86, R104, R126, K203, H209, and Y239. Their 
contribution to productive binding and transport is currently unknown. To investigate 
the role of each residue found to interact with SA, site-directed mutagenesis was used to 
substitute each interacting residue with either alanine or an amino acid with more 
conserved properties. Fluorescence titrations of SA, produced and purified in vitro, with 
wild-type (WT) or mutant rHtsA were used to determine the effect that each 
substitution had on the binding affinity of HtsA for S A. Growth curves and disk- 
diffusion assays were completed on strains expressing mutated or WT HtsA to 
determine the biological significance of each mutation under SA-dependant growth 
conditions. These studies have confirmed significant roles in SA binding and transport
iii
for HtsA residues R104, R126, and H209, strengthening the conclusions drawn from the 
HtsA crystal structure and providing new insight into the mechanism of SA-dependant 
iron uptake in S. aureus.




Some of the work presented in this thesis was contributed by Dr. Michael 
Murphy and Dr. Jason Grigg. They solved the apo and holo crystal structures of rHtsA 
and contributed figures for the HtsA binding pocket and conformational changes.
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Staphylococcus is derived from the Greek work staphylé which means “bunch of 
grapes”, which describes their characteristic grape-like appearance when observed under 
a microscope (30). They belong to the family Staphylococcaceae which includes 
Jeotgalicoccus, Micrococcus, Nosocomicoccus, and Salinoccus. Staphylococci are 
spherical (approximately 1 pm in diameter), Gram-positive, facultative-anaerobes, that 
are non-motile and non-spore-forming. Depending on growth conditions, they can be 
found alone, in pairs, strings, or in clusters because their cell division occurs in more 
than one plane. They tend to form capsules in vivo, however, they produce little to no 
capsule when grown under standard laboratory conditions (105). They have a thick cell 
wall that consists of peptidoglycan with glycine cross-links, and wall teichoic acids and 
lipoteichoic acids (30).
1.1.2. Staphylococcus aureus
Staphylococcus aureus is a commensal and a pathogen. It produces a yellow 
carotenoid pigment, staphyloxanthin, distinguishing it from other staphylococci (123). S. 
aureus is one of few coagulase-positive staphylococci (CoPS) that harbour the gene 
encoding coagulase in their genome. The enzyme coagulase interacts with host factors in 
serum to clot blood, which may aid in immune evasion (126). S. aureus is the best 
studied species of staphylococci however, some notable coagulase-negative 
staphylococci (CoNS) include S. saprophyticus, S. haemolyticus, and S. epidermidis (72).
One of S. aureus’ ecological niches is the anterior nares of humans. Approximately 20- 
30% of the population are persistent S. aureus carriers, and an additional 30% are 
intermittent carriers (152). More than eighty strains of S. aureus and 6 CoNS strains 
have had their complete genome sequenced. S. aureus genomes range from roughly 2.8 
to 2.9Mbp and have an average G + C mol % content of 33% (69).
1.1.3. S. aureus pathogenesis
S. aureus is a significant human pathogen and is frequently responsible for blood, 
skin, soft tissue, and lower respiratory tract infections in North America and Europe (38). 
It is also the leading cause of nosocomial infections in the United States (140) and 
community-acquired (CA) infections are becoming increasingly prevalent (77). 
Furthermore, the CA strains tend to be more invasive than the traditional hospital 
acquired strains (79). S. aureus can infect multiple host tissue environments and cause 
mild infections including impetigo, pimples, boils, and food poisoning to more severe 
infections including toxic shock syndrome, osteomyelitis, pneumonia, necrotizing 
fasciitis, bacteraemia, sepsis, and staphylococcal scalded skin syndrome (150).
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The ability of S. aureus to produce productive infections in many different host 
tissue environments is largely due to its enormous repertoire of virulence factors. S. 
aureus encodes both structural and secreted virulence factors and many of them are 
encoded on mobile genetic elements (MGEs). Through transfer of genetic information, 
the MGEs increase the heterogeneity of S. aureus virulence factors and resistance 
determinants (95). Antibiotic resistance will be discussed in greater detail below. Many 
types of MGEs are found in S. aureus including plasmids, transposons, insertion 
sequences, bacteriophages, pathogenicity islands, and staphylococcal cassette 
chromosomes. Most staphylococcal MGEs are regulated by core genome global 
regulators allowing for careful regulation of virulence factor expression (37).
Adhesion of S. aureus to host molecules is achieved through microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs) (111). The 
MSCRAMM family of proteins includes a fibronectin-binding protein (FnBPA), a 
collagen-binding protein (Cna), clumping factor A (ClfA), and a fibrinogen-binding 
protein (142, 111), among others. Other surface proteins include protein A (Spa), which 
binds the Fc domain of immunoglobulin G (IgG), aiding immune evasion (142). It can 
also mediate attachment to host von Willebrand factor, a blood glycoprotein involved in 
hemostasis (63). S. aureus also has an elastin binding protein (EbpS) and can bind other 
host plasma and extra-cellular matrix (ECM) components, however, the mechanisms
1.1.4. S. aureus virulence factors
remain unclear.
Different strains of S. aureus have the ability to secrete a large variety of 
virulence factors, including exoenzymes such as proteases, lipases, and nucleases, and
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exotoxins, including a , p, y, and 5 toxins, Panton-Valentine Leukocidin (PVL), 
superantigens (SAgs), and superantigen-like proteins, and exfoliative toxins A and B. 
Collectively, these factors function to provide nutrients, modulate host immune 
mechanisms and damage tissues (36).
Regulation of staphylococcal virulence factors is essential for maintaining 
productive infections. Two global regulator families are responsible for proper virulence 
factor regulation. They are two component regulatory systems (TCRS) and the 
staphylococcal accessory regulator (SarA) protein family (16). Of 16 known S. aureus 
TCRSs the most notable system involved in pathogenesis is the accessory gene regulator 
(agr) quorum sensing system (22). The agr system is cell density dependant and at 
elevated cellular densities, such as those during post-exponential growth phase, the agr 
system increases secreted toxin production and decreases surface protein expression 
(148, 107). Additional TCRSs involved ins', aureus pathogenesis include SaeRS, (55, 
56), ArlRS (48, 49), and SrrAB (154).
The SarA protein family consists of DNA-binding proteins that directly or 
indirectly regulate at least 120 staphylococcal genes. Furthermore, it has been 
demonstrated that SarA is required for the complete activation of agr expression (21). 
SarA levels are highest during the late exponential phase of growth leading to the 
highest expression levels of the fibronectin and fibrinogen binding protein adhesins and 
toxins that promote dispersion (22). Additionally, it represses Spa and protease
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expression (22). SarA elicits its effects directly by binding gene promoters, indirectly via 
downstream effects of regulons, or by stabilizing mRNA transcripts (22, 121).
1.1.5. S. aureus antibiotic resistance
S. aureus antibiotic resistance is a growing problem in nosocomial and CA 
infections. S. aureus develop resistance through a number of mechanisms. One of the 
first mechanisms identified was the production of a secreted penicillinase (BlaZ), which 
hydrolytically cleaves (3-lactams (19). More recently, methicillin resistant 
Staphylococcus aureus (MRSA), which is propagated on MGEs (SCCmec), have 
become a growing concern (61). There are currently 8 SCCmec types, abbreviated I-VIII, 
which have been subdivided into 5 classes. Each class contains mec A, which encodes a 
low-affinity penicillin binding protein (PBP2a) that prevents binding of methicillin or 
other 13-lactam antibiotics (20).
In addition to mecA, other antibiotic resistance determinants are frequently 
associated with the SSCmec MGEs. These include resistance to erythromycin (ermB, 
ermC), spectinomycin (aad9 or spc), tetracycline (tet), aminoglycosides (aacA-aphD), 
bleomycin (ble), and tobramycin (ant4 ’) (36). More recently, staphylococci have 
acquired vancomycin resistance from enterococci resulting in vancomycin-resistant S. 
aureus (VRSA) (151). Vancomycin resistance is mediated by VanA and VanH which 
synthesize a D-Ala-D-Lac precursor that has reduced affinity for glycopeptide 
antibiotics (89). In addition, VanX mediates the elimination of the D-Ala-D-Ala peptides 
that are susceptible to glycopeptide antibiotics, thus eliminating the drug targets (88).
Consequently, there is a drastic need for the identification of new therapeutic targets, 
such as the interruption of access to the essential nutrient iron.
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1.2. Iron
Iron is an essential nutrient for almost all living organisms. The only known 
exceptions are some lactobacilli (1) and spirochaetes (116). Iron exists predominantly in 
two oxidative states, ferrous Fe2+(FeII) or ferric Fe3+(FeIII). The ability to transition 
between those oxidative states is essential for the catalytic roles that iron has in most 
organisms (114). Indeed, iron can be found in essential enzymes involved in the electron 
transport chain, carbon utilization, DNA replication, and oxygen metabolism (4).
1.3. Iron solubility
Although iron constitutes a significant proportion of the earth, the vast majority 
of it is unavailable for biological activity. This is largely due to the rapid oxidation of 
ferrous iron by molecular oxygen (104). The resulting iron-hydroxide precipitates are 
stable and extremely insoluble culminating into a final free iron concentration of 
approximately 10'9 M at a neutral pH (118).
1.4. Iron in the human host
Further evidence of iron’s biological importance is demonstrated by a human 
host’s non-specific defence mechanisms that function to limit iron availability. Most 
iron is found intracellulary complexed to haemoglobin (76%) or ferritin (23%) (109). 
Additionally, extracellular iron-binding proteins, especially transferrin and lactoferrin,
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further depress the free iron available leading to essentially no free iron in the host (118). 
The abundance of iron binding proteins involved in proper iron homeostasis and 
maintenance of low extracellular levels within a human host highlight iron’s importance. 
Heightened iron levels can bolster infections, as patients with thalassemia or other forms 
of iron overload are more susceptible to infections (149), or it can lead to the production 
of free radicals under aerobic conditions. However, insufficient iron has severe 
consequences on essential cellular processes including oxygen transport, electron 
transport, and RNA and DNA synthesis. Furthermore, during an infection iron is 
actively sequestered by the reticuloendothelial system (90). Therefore, iron limitation in 
the human host is a significant obstacle that microorganisms must overcome in order to 
sustain infections.
1.5. Regulation of iron uptake
Proper organization and regulation of iron transport is an essential process. The 
most important iron-regulatory protein is the ferric uptake regulator (Fur), an iron- 
dependant repressor protein found in both Gram-negative and Gram-positive bacteria, 
including S. aureus (146), and more than 60 homologues have been found (15). Other 
iron-responsive repressor proteins have been identified, such as RirA-type regulatory 
proteins; however, Fur is by far the most important (139, 146). Under physiologically 
adequate levels of cellular iron Fur binds ferrous iron. Dimeric Fur-Fe(II) complexes 
then bind specific DNA regulatory sequences at Fur boxes, a 19-bp inverted repeat, 
located within the operator region of target genes and repress transcription (62, 158). Fur 
regulates more than 90 E. coli genes in this manner (139). Additionally, it has been
demonstrated that Fur can also indirectly activate genes through repression of small 
RNA silencing molecules (98) and directly upregulate other genes (35).
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1.6. Bacterial iron acquisition strategies
Many organisms have developed means of scavenging human host iron. Due to 
iron’s strict limitation, multiple strategies are frequently employed by successful 
pathogens. These systems work in concert to access and internalize host iron sources.
For instance, some bacteria secrete toxins that lyse host cells in order to gain access to 
intracellular iron stores. Additionally, other systems can recognize host extracellular iron 
containing sources.
1.6.1. Ferric reductases
One mechanism that bacteria use to acquire host iron is to reduce highly 
insoluble ferric iron (lO'18 M) to much more soluble ferrous iron (0.1 M) at a pH of 7.0 
(4). Listeria monocytogenes has two of the best-characterized examples of ferric 
reductases. One is membrane-bound with a broad range of activity and the other is 
secreted and can reduce and remove iron from transferrin (28). Ferric reductase activity 
has now been shown in a number of bacterial (46), fungal (43), and plant species (44). 
Additionally, some organisms have a specific transport system for ferrous iron. For 
example, the feo  system which was first identified in E. coli, is also present in S. 
enterica (11) and H. pylori, other colonizers of the human intestinal tract and stomach, 
respectively. It is anaerobically induced where conditions are more permissive for 
ferrous iron (76). A homologous system has also been identified in S. aureus (65).
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1.6.2. Host iron-binding protein receptors
Some bacteria encode surface receptors that specifically recognize human host 
iron-binding glycoproteins as an iron source. Neisseria gonorrhoeae has two transferrin 
(Tf)-binding proteins, TbpA and TbpB (130), and two lactoferrin (Lf)-binding proteins 
that form Tf and Lf receptors on its cell surface (131). Other human pathogens, such as 
Haemophilus influenzae, have similar receptors (132). Both receptors bind Tf or Lf and 
remove iron for internalization without transporting the glycoproteins across the outer 
membrane (OM). These OM receptors have a (3-barrel structure similar to porins 
however, an N-terminal globular domain prevents free diffusion of substrates into the 
periplasm. Instead, transport is dependent on TonB-ExbB-ExbD, an inner membrane 
embedded protein complex that interacts with a TonB box within the N-terminal 
globular domain of the OM receptors in order to facilitate transport (13). Iron is then 
bound by periplasmic substrate binding proteins which deliver the cargo to inner 
membrane ABC transporters which shuttle the cargo through the inner membrane (IM) 
in an ATP-consuming fashion (3).
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1.6.3. Heme iron acquisition
Heme is a protoporphyrin ring with a centrally located iron atom. It is a 
hydrophobic prosthetic group found in many proteins and it is the most abundant 
potential iron source in the human host (109). It is found primarily intracellulary, 
however, following lysis of erythrocytes it is released into the extracellular milieu (115). 
In order to prevent damage from reactive heme molecules, it is quickly sequestered by 
hemopexin (73), lipoprotein (101), haemosiderin (71), or haptoglobin (53). Host 
macrophages will then internalize and clear the haptoglobin-hemoglobin or hemopexin- 
heme complexes, protecting the host from damage and limiting bacterial heme access 
(83). Under physiological conditions this highly efficient process reduces heme 
concentrations beneath detection limits in human serum (115). However, during an 
infection many bacteria, including S. aureus, secrete haemolysins that lyse erythrocytes 
and elevate the extracellular heme concentration (8). Several Gram-positive and Gram­
negative bacterial systems have been identified that use heme as an iron source. Indeed, 
there are three types of heme transport systems that can obtain heme from host sources 
including hemopexin, haemoglobin, heme-albumin, and haemoglobin-haptoglobin (145).
1.6.3.1. Direct heme uptake systems
Direct heme uptake systems have been identified in Gram-negative and Gram­
positive bacteria. In Gram-negative bacteria, heme is bound at the outer membrane and 
transported into the periplasm in a TonB-dependant fashion. It is then complexed to a 
heme transport protein (HTP) and shuttled into an ABC-transporter for internalization
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into the cytosol (145). The Pseudomonas aeruginosa phuR-phuSTUVW is an example of 
a direct heme uptake system that contains an outer membrane receptor (PhuR), an HTP 
(PhuS), an ABC-transporter (PhuUVW), and a cytosolic protein (PhuS) (108). Similar 
systems are utilized by several other Gram-negative pathogens including Yersinia pestis, 
Campylobacter jejuni, and E. coli (102, 144, 147). There are fewer well-described heme 
transport systems in Gram-positive bacteria. S. aureus encodes an iron-regulated surface 
determinate system (Isd) that is composed of four cell wall-anchored proteins 
(IsdABCH), an ABC transporter (IsdDEF), and two heme oxygenases (IsdGH) (120). 
The surface proteins, IsdB and IsdH, bind haemoglobin or haemoglobin-haptoglobin 
(41) from which IsdA extracts heme and passes it to IsdC. Heme is then shuttled to 
IsdDEF which transports it across the cell membrane into the cytoplasm (106). The 
heme oxygenases then extract the iron for incorporation into proteins or storage (99, 
120). The Isd locus is also found in other Gram-positive pathogens (145) however, 
Corynebacterium spp. and Streptococcus spp. use a direct heme uptake system that is 
distinct from Isd (2, 157). In C. diptheriae, htaCA hmuTUV-htaB encodes two heme 
receptors (HtaA & HtaB), a heme binding protein (HmuT) and an ABC-transporter 
(HmuUV) that internalizes the heme (2).
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Both Gram-positive and Gram-negative hemophores have been identified. A 
hemophore is a secreted heme-binding protein that scavenges heme and is then 
recognized by a surface receptor that mediates heme uptake. Two Gram-negative 
hemophore systems have been characterized (145). The HasA hemophore system 
consists of a hemophore (HasA), an exporter (HasDEF), a receptor (HasR), two 
regulatory proteins (HasI and HasS) (52, 124) and is TonB- or the TonB homolog, 
HasB-dependant (110). This system has been identified in Serratia marcescens, P. 
aeruginosa, P. fluorescens, and Y. pestis (74, 91, 125). The HxuA hemophore system 
has only been identified in Haemoplilus influenzae type b and it consists of a hemophore 
(HxuA) that binds heme-hemopexin complexes, an exporter (HxuB), and a receptor 
(possibly HxuC) (26). Bacillus anthracis encodes the only known Gram-positive 
hemophores, IsdXl and IsdX2. The hemophores are unique components of an Isd heme 
uptake system that is similar to but distinct from the S. aureus Isd (51). IsdXl can 
remove heme from haemoglobin before passing it to IsdX2 or IsdC, which then 
transports heme into the cell through the Isd system (47).
I.6.3.2. Hemophores
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Another common iron acquisition strategy that is utilized by an large number of 
bacteria is siderophores. A siderophore is a secreted, small (500-1500 Da), high-affinity 
Fe(III) chelator. There is an incredible diversity of siderophore structures and origins 
with more then 500 currently identified and structural information for more than half of 
them (65). Siderophores have been identified in plants (44), fungi (45), and 
microorganisms (50).
I.6.4.I. Siderophore biosynthesis
There are two classes of siderophore biosynthesis: nonribosomal peptide 
synthesis (NRPS) and nonribosomal peptide synthesis-independent (NIS) (18). NRPS 
synthesis occurs in a step-by-step process, usually through the addition of amino acids or 
their derivatives to a proteinaceous backbone by a large modular multienzyme (29). 
These complexes are not limited to the production of siderophores but are also 
responsible for the synthesis of most microbial peptide secondary metabolites including 
some antibiotics such as penicillin (129) and vancomycin (141). Some notable NRPS 
siderophores include enterobactin and yersiniabactin (119). NIS pathways usually rely 
on multiple synthetases that combine dicarboxcylic acids with diamines, alcohols, and 
amino alcohols (18). The best-known example of an NIS siderophore is aerobactin, 
assembled by two enzymatic synthetases (34). Interestingly, the siderophore 
petrobactin’s synthesis is partially completed by both NRPS and NIS systems (85, 113).
1.6.4. Siderophores
15
Although there is incredible diversity in the structure of siderophores, they can be 
classified according to their iron-coordinating moieties. Three types of siderophore iron 
coordinating moieties have been documented (Fig. 1). The first type of functional group 
is a hydroxymate group, which uses both carbonyl and aminohydroxyl groups to 
coordinate iron as seen in desferrioxamine B (Fig. 2) (143). The second functional group 
incorporates a catecholate structure, which coordinates iron with two adjacent hydroxyl 
groups as seen in enterobactin (Fig. 2) (75). Lastly, there are polycarboxylate groups, 
which coordinate iron with either a-hydroxycarboxylates or carboxylic acid moieties as 
seen in staphyloferrin A (SA) (Fig. 2). This thesis will primarily focus on SA, an a- 
hydroxycarboxylate siderophore (100). Additionally, there are mixed-type siderophores 
that use combinations of the above functional groups to coordinate iron, such as 
aerobactin (Fig. 2) (65).
Although siderophores use a hexadentate structure to coordinate Fe(III) with an 
octahedral geometry, the stoichiometric relationship between siderophores and Fe(III) 
varies (65). Depending on the number of coordinating residues that a siderophore 
contains, they can form mono-, di-, or multi-nucleate iron complexes with one or more 
siderophore molecules involved (66). Additionally, some siderophores rely on solvent 




Figure 1. Types of siderophore iron coordinating moieties. Illustrated are the three 
major siderophore functional groups involved in Fe(III) coordination; catecholate, 
hydroxamate, and carboxylate. Each group is bi-dentate. Red oxygen atoms can donate 




Figure 2. Types of siderophores. Illustrated are examples of the four types of 
siderophores classified according to their Fe(III)-coordinating moieties. Catecholate- 








1.7. S. aureus siderophores
S. aureus has a profound ability to adapt to host environments and has multiple 
methods of accessing host iron. Not surprisingly, several staphylococcal genetic loci 
have been identified that are involved in siderophore biosynthesis or transport. To date, 
two S. aureus siderophores have been identified; staphyloferrin A (SA) (80, 100) and 
staphyloferrin B (SB) (40, 60).
1.7.1. Staphyloferrin A
SA is a 480 Da a-hydroxycarboxylate siderophore that was first isolated from 
iron-starved culture supernatant of S. hyicus (100). It is comprised of two citrate 
molecules linked, via amide bonds, to D-omithine and has the chemical identity of 
7v2,A5-di-(l-oxo-3-hydroxy-3,4-dicarboxybutyl)-D-ornithine. It is stable between 4°C 
and 80°C in neutral aqueous solution (80). The SA biosynthesis genes were identified 
through bioinformatics searches using the aerobactin NIS synthetases IucA and IucC as 
queries. A four-gene locus, sfaABCD, was identified in all sequenced staphylococci 
including S. epidermidis, S. saprophyticus, S. aureus, and S. haemolyticus (7). SA was 
also identified in culture supernatants of S. aureus and S. epidermidis and its production 
is stimulated by supplementation with D-omithine (100). The sfa locus consists of a 
three-gene operon, sfaABC, and a divergently transcribed gene, sfaD. Upstream from 
two divergent promoters, intergenically between sfaA and sfaD, are two Fur box 
consensus sequences that provide Fur transcriptional control in S. aureus (7). However, 
constitutive production of SA in some CoNS suggests a lack of Fur regulation (96).
The genes of the sfaABCD locus encode two NIS synthetases, SfaB and SfaD, a 
putative pyridoxal-5’-phosphate (PLP)-dependant D-ornithine racemase, SfaC, and a 
putative SA efflux protein, SfaA (27). Cotton et al. demonstrated that purified SfaB and 
SfaD can generate SA in vitro from citrate and D-omithine (27). The complete 
biochemical synthesis reaction is illustrated in Figure 3. SfaD is responsible for the 
committing step of synthesis, condensing citric acid and D-omithine, and SfaB 
completes the molecule through condensation of citric acid and the 5-citryl-D-ornithine 
intermediate.
Chromosomal deletion of sfaABCD in S. aureus abrogates SA production however, 
if SB is still produced it does not result in an observable growth defect in mammalian 
serum (SB will be discussed below). Although this suggests that SA may not be the 
major contributor of transferrin iron, a more drastic growth deficit is observed in an SA 
and SB deficient mutant than a SB deficient mutant alone (7). Furthermore, SA has been 
demonstrated to remove iron from human and porcine transferrin (103, 6). Chromosomal 
deletion of sfaABCD in S. aureus can be complemented via plasmid-bome sfa genes 
from S. aureus or S. epidermidis, demonstrating functional conservation of the 
staphylococcal sfa locus despite protein sequence identities of 50-80% (7).
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1.7.2. Staphyloferrin B
SB is a 448 Da a-hydroxycarboxylate siderophore that was initially purified and 
structurally characterized from iron-starved culture supernatant of S. hyicus (60). It is 
comprised of L-2,-3-diamino-propionic acid (DAPA), citrate, ethyldiamine (EDA), and 
a-ketoglutarate (a-KG) (40). The SB biosynthesis genes were also identified through 
bioinformatic searches of the aerobactin NIS synthetases IucA and IucC as queries. A 
nine-gene operon, sbnABCDEFGHI, was identified in S. aureus (32). SB was also 
identified in culture supernatants of S', aureus and some CoNS (100, 40). Interestingly, 
Gram-negative Ralstonia solanacearum and Cupriavidus metallidurans also produce SB 
(9, 5). The sbn operon contains a Fur box consensus sequence located in the operator 
region that provides Fur-dependent transcriptional control of the operon (32).
The genes of the sbnABCDEFGHI operon encode three NIS synthetases, SbnC, 
SbnE, and SbnF, a putative ornithine cyclodeaminase, SbnB, a putative L-O-acetylserine 
sulfhydrylase, SbnA, a putative SB efflux protein, SbnD (32), a PLP-dependant 
decarboxylase, SbnH, and two proteins with currently undefined functions, SbnG and 
Sbnl (23). Cheung et al. demonstrated that purified SbnC, SbnE, SbnF, and SbnH can 
generate SB in vitro from DAP A, a-KG and citrate (23). SbnE is responsible for the first 
step of synthesis, condensing DAPA and citric acid to form a citryl-L-2,3-diamino- 
propionic acid intermediate. It is then decarboxylated by SbnH, forming citryl- 
diaminoethane, before a second DAPA molecule is condensed onto it by SbnF. Finally, 
SbnC completes SB through condensation of a-KG and L-2,3-diaminopropionyl-citryl-
diaminoethane.
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Chromosomal deletion of sbnABCDEFGHI in S. aureus abrogates SB production 
and impairs growth in serum. Although growth is not completely abolished, presumably 
due to the presence of SA, it suggests a significant role in iron acquisition from 
transferrin (7).
1.8. Siderophore-mediated iron acquisition
Gram-positive and Gram-negative bacteria require active transport systems to 
transport ferric-siderophores across their cell membrane because they are too large for 
passive diffusion. Although smaller siderophores (less than 600Da) may passively 
diffuse through porins in the Gram-negative outer membrane, siderophores generally 
require an energy-dependant carrier protein to cross this barrier (14). The cell wall of 
Gram-positive bacteria does not represent a barrier to movement of ferric-siderophores.
1.8.1. ATP-binding cassette transporters
Gram-positive and Gram-negative bacteria use ATP-binding cassette (ABC)- 
family transporters to import ferric siderophores across their cell membrane into the 
cytoplasm. They belong to one of the largest paralogous sequence superfamilies and 
consist of a receptor, a transmembrane permease, and a highly conserved ATPase (128). 
More than 600 ABC-transporters have been identified (33) and they are found 
ubiquitously among all genera of the three kingdoms of life (70).
There are three major classes of ABC-systems; importers, exporters, and a third 
class that is involved in mRNA translation and DNA repair. Each class is further 
subdivided into subclasses and families and this thesis will focus on class III binding-
protein-dependant (BPD) importers (33). These ABC-transporters have separate 
polypeptide TM, ABC, and substrate binding domains (117). The generic structure of 
ABC-transporters can be seen in Figure 4. Substrates for these ABC-transporters include 
mono- and oligosaccharides, ions, amino acids, short peptides, ferric-siderophores (the 
focus of this thesis), metals, polyamine cations, opines, and vitamins (39). The best- 
studied examples of these ABC-transporters are the high-affinity histidine and maltose 
transport systems of Salmonella enterica serovar Typhimurium and E. coli (54).
Many iron ABC-transporters are important virulence factors (64). Furthermore, 
many bacteria encode transporters for exogenous siderophores (i.e. xenosiderphores; 
siderophores produced by other organisms). For example, the S. aureus Fhu transporter 
is involved in the uptake of hydroxamate siderophores (produced mainly by fungi) 
despite lacking the necessary biosynthesis machinery to produce this type of molecule
Figure 4. Schematic of Gram-negative and Gram-positive siderophore-mediated iron- 
uptake pathways. A) Gram-negative bacteria have outer-membrane receptors that bind 
and transfer siderophores to periplasmic binding proteins in a TonB-ExbB-ExbD- 
dependent process. The ligand-bound periplasmic binding protein then associates with 
its cognate ABC-transporter in the inner membrane, which transports the siderophore 
into the cytoplasm. B) Gram-positive bacteria have lipoprotein receptors, homologous to 
Gram-negative periplasmic binding proteins, which bind siderophores and associate with 
their cognate ABC-transporter in the cellular membrane, which transports the 
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1.8.2. S. aureus siderophore transporters
Given that S. aureus is such a successful human pathogen it is not surprising that 
many iron-regulated ABC-transporters are encoded within its genome. To date, one 
heme transporter (IsdEF) (32) and four siderophore transporters have been identified and 
characterized (57, 58, 6). The latter transporters are HtsABC (Fe(III)-SA), SirABC 
(Fe(III)-SB), FhuCBG-Dl-D2 (Fe(III)-hydroxamate siderophores) and SstABCD 
(Fe(III)-catecholamines/catechols) (6).
1.8.3. The staphyloferrin B receptor: SirA
The sir locus encodes a lipoprotein receptor, SirA, and two heterodimeric 
permeases, SirBC (32). FhuC provides the ATPase activity that is necessary for Fe-SB 
transport (138). A chromosomal deletion of sir A or sirB abolishes SB transport in S. 
aureus (32). Also, heterologous expression of sirABC in S. epidermidis allows SB- 
dependant growth (5). The crystal structures of apo- and holo-SirA have been solved, 
positively identifying SB in the substrate binding-pocket (57).
The Fe-SB-rSirA crystal structure was among the first Gram-positive 
siderophore receptors to be structurally characterized (57). It has a class-III binding fold 
between separate N- and C-terminal domains that are linked by a single a-helix (57). 
Both N- and C-terminal domains contain a central parallel (3-sheet that is surrounded by 
short a-helices (57). Although most class III binding protein crystal structures reveal 
that ligand binding results in either subtle or hinged-motion conformational changes, 
both the Fe-SB-SirA and Fe-SA-HtsA crystal structures reveal localized conformational
changes in the C-terminal loops of the binding site. However, different regions of each 
receptor’s C-terminal domain undergo the largest conformational changes (57, 58). 
Furthermore, fluorescence quenching experiments using Fe-SB, Fe-SA, and Fe- 
desferrioxamine demonstrated that SirA is highly specific for Fe-SB. Therefore, the 
unique structural features of HtsA and SirA are likely responsible for their ability to 
distinguish between the two a-hydroxycarboxylate siderophores (57, 58).
SirA forms a total of nine contact points with Fe-SB. Three arginine residues 
form five hydrogen-bonds (H-bonds) with three Fe-SB oxygen atoms and two nitrogen 
atoms. R125 forms two salt bridges with the Fe(III) coordinating carbonyl of the a-KG 
component and citrate group (57). R201 forms a H-bond with the carbonyl oxygen that 
links the Fe-SB DAPA and citrate groups and R206 forms salt bridges to the a-KG and 
citrate components. Finally, T144 forms an H-bond with the Cl 1-C12 amide linkage, 
Y208 forms an H-bond with the citrate carboxylate group, and N304 forms an additional 
polar contact with the citrate carboxylate group. Comparison of apo- and holo-SirA 
revealed that the majority of intradomain conformational change was maximal in the C- 
terminal loops. The movements help to occlude Fe-SB in the binding pocket, reducing 
solvent exposure to 23.6%. Among the SirA residues, N263 moves the greatest distance 
of 11.3 A and others are brought into closer proximity with Fe-SB, likely facilitating 
some of the H-bonds identified (57).
1.8.4. The staphyloferrin A receptor: HtsA
The hts locus was first described and named as a “heme-transport system”, 
following the observation that transposon disruption of hts resulted in preferential uptake 
of transferrin Fe(III) over heme Fe(II) (137). However, a chromosomal deletion of 
htsABC abolishes SA transport in S. aureus (7). Furthermore, the crystal structures of 
apo- and two forms of holo-HtsA have been solved, positively identifying SA in the 
substrate binding-pocket (Figure 5A, B, and C)(7, 58). It was the first Gram-positive (7) 
and first a-hydroxycarboxylate siderophore receptor to be structurally characterized 
(58). Table 1 lists the dissociation constants (KJ) of Fe-SA-rHtsA and several related 
proteins. Their significance will be discussed in more detail in later sections.
Figure 5. HtsA crystal structure. A) Surface electrostatics of HtsA. The binding groove 
is a large positively charged region. Blue, white, and red indicate positive, neutral, and 
negative potential, respectively. B) HtsA undergoes localized conformational changes 
following binding of Fe-staphyloferrin. Illustrated is an overlay of the open and closed 
forms and the apo-conformations of the HtsA crystal structures. Open conformation, red; 
closed conformation, blue; apo-conformation, green. Staphyloferrin A is shown in the 
binding pocket of the open-conformation. C) Coordination and binding of staphyloferrin 
A in the HtsA binding pocket. On the left is the open conformation of staphyloferrin A 
in the HtsA binding pocket. On the right is the closed conformation of staphyloferrin A 
in the HtsA binding pocket. HtsA residues forming contacts with SA are cyan sticks, 
with carbon, nitrogen, oxygen, and iron shown as green, blue, red, and orange, 
respectively. Hydrogen-bonds are represented by dashed lines (58). In the open 
conformation R299 is modeled in two positions within H-bonding distance from Fe-SA.
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Table 1. Dissociation constants for receptor-ferric-siderophore complexes
Protein“ Organism Ligand Dissociation 
Constant (K d )
Reference
HtsA S. aureus staphyloferrin A Low nM (58)
F eu A B. cereus bacillibactin 19 nM (155)
Feu A B. cereus enterobactin 12 nM (155)
FatB B. cereus 3,4-DHB 1.3 nM (155)
FatB B. cereus petrobactin 127 nM (155)
FpuA B. cereus petrobactin 175 nM (155)
YfiY B. cereus schizokinen 34 nM (155)
YxeB B. cereus desferroximine 18 nM (155)
YclQ B. subtilis petrobactin 113 nM (156)
FhuD E. coli F erric-hy droxamates 300-7900 nM (122)
FpvA6 P. aeruginosa pyoverdin 0.37 nM (68)
FhuA* P. aeruginosa ferrichrome 0.65 nM (68)
FplA* P. aeruginosa pyochelin 0.54 nM _i68)________
* Proteins are class III ligand-binding proteins unless otherwise stated. 
b Gram-negative Outer membrane receptor proteins.
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HtsA has a class-III binding fold between separate N- and C-terminal domains 
that are linked by a single a-helix (58). Similar to SirA, both N- and C-terminal domains 
contain a central parallel (3-sheet that is surrounded by short a-helices (57, 58). Its 
structure is similar to other class III binding proteins including BtuF {E. coli B12 uptake) 
(10, 78), TroA (E. coli Zn2+ uptake) (86, 87), FhuD (E. coli ferrichrome uptake) (24, 82), 
and ShuT (Shingella dysenteriae heme uptake) (67) however, it has a novel form of 
ligand entrapment (58). The two holo-HtsA forms represent distinct open and closed 
conformations. The conformational change results from isolated movements of three 
loops within the C-terminal domain and is unique among class III binding proteins (Fig. 
5B) (58).
HtsA forms six contact points with Fe-SA in the open conformation (Fig 5C). 
Five arginine residues form hydrogen bonds (H-bonds) with oxygen atoms of Fe-SA. 
R104 and R126 form H-bonds with Fe-SA. R299 is modeled in two positions within H- 
bond proximity of a Fe-SA ornithine hydroxyl group and R304 and R306 form H-bonds 
with a terminal Fe-SA carboxylate group. H209 forms another H-bond with the Fe-SA 
ornithine hydroxyl group and four water molecules are modeled within H-bond 
proximity of the Fe-SA ornithine carboxylate group, carbonyl group, and two 
carboxylate groups of one of the citrate molecules (58). Loop movements leading to the 
closed conformation result in the additional contacts with Fe-SA, shift it deeper into the 
binding pocket, and reduce solvent exposure from 33.0 to 14.5%. Y239 moves the 
greatest distance, 12.1 A, before forming a H-bond with a citrate carbonyl group. The 
closed conformation also allows K203 and R86 to H-bond with Fe-SA carboxylate
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groups (Fig. 5C). Although several of the contact points remain the same, several of the 
H-bond lengths are reduced in the closed structure (58).
1.9 Research objectives
The goal of this research is to further characterize S. aureus SA transport and to 
provide a model system for a-hydroxycarboxylate siderophore transport. The first 
research objective was to synthesize and purify SA for use in receptor binding and 
bacterial growth assays. The second research objective was to use site-directed 
mutagenesis to mutate HtsA residues predicted by the holo-HtsA crystal structure to 
mediate binding and/or transport of Fe-SA. Finally, the last research objective was to 
determine the effects of each residue substitution on Fe-SA binding affinity and their 
biological significance under iron-restricted or SA-dependent growth conditions.
Chapter 2 -  Materials and Methods
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2.1. Bacterial strains and growth conditions
The bacterial strains used in this study are described in Table 2. Unless otherwise 
indicated, bacteria were cultured at 37°C. Antibiotics were used at the following 
concentrations: for E. coli, ampicillin (Ap) 100 pg mL'1, kanamycin (Km) 30 pg mL'1, 
choramphenicol (Cm) 30 pg mL'1, and for S. aureus, Km 50 pg mL'1, Cm 5 pg mL'1, 
neomycin (Nm) 50 pg mL'1, tetracycline (Tc) 4 pg mL'1, erythromycin (Em) 3 pg mL'1. 
For molecular-genetic manipulations, E. coli was grown in Luria-Bertani broth (LB), 
and S. aureus was grown in tryptic soy broth (TSB). For experiments completed under 
iron-limiting growth conditions, Tris-minimal succinate (TMS), prepared as described 
(135), was used. To further control the bioavailable iron, growth media was 
supplemented with 50 pM FeCf, 10 pM ethylenediamine-di-o-hydroxyphenylacetic 
acid (EDDHA) (LGC Promochem), or treated with 10% w/v Chelex® 100 resin (Bio- 
Rad) overnight at 4°C and supplemented with 20% v/v heat-inactivated horse-serum. All 
solutions and growth media were made with water purified by a Milli-Q purification 
system (Millipore Corp). Solid media was obtained by addition of 1.5% w/v Bacto-agar 
(Difco). Cultures were stored at -80°C in 15% v/v glycerol.
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Table 2. Bacterial strains used in this study
Strain Description“ Source or reference
S. aureus
Newman Wild-type clinical isolate (42)
RN4220 rtTmk+; accepts foreign DNA (81)
H1497 
E. coli
Newman AhtABC::Tc As7/vl::Km; TcR KmR (7)
DH5a cp8o dLacZAMl 5 recAl endAl gyrA96 thi-1 
hsdR17{rk‘mk+) supE44 relAl deoR A(lacZYA- 
argF) U169
Promega
ER2566 F T  fhuA2 [Ion] ompT lacZ::T7 genel gal 
sulA ll A(mcrC-mrr)\\4::lS 10R(mcr- 
73::mimTnlO)2 R(zgb-2\0::Tn 10) 1 (Tets) 
endAl \dcni\
New England Biolabs
BL21 F_, ompT, hsdSs (rs-, ms-), dcm, gal, 7(DE3), 
pLysS, CmR.
Promega
Abbreviations: TcR, KmR, and CmR, resistance to tetracycline, kanamycin, and chloramphenicol, 
respectively.
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2.2. Recombinant DNA methodology
2.2.1. Plasmid isolation from E. coli
The plasmids used in this study are described in Table 3. Manipulation of 
recombinant DNA was completed as described (127). Plasmid DNA was isolated from E. 
coli using QIAprep mini-spin kits (QIAgen) or E.Z.N.A™ Plasmid Miniprep Kit II 
(Omega Bio-Tek), according to the manufacturer’s directions. All centrifugation was 
completed at 14 000 x g, unless otherwise indicated. Typically, approximately 2 mL of 
stationary phase E. coli was harvested by centrifugation (10 000 x g) and resuspended in 
250 pL of PI buffer. Cell lysis was achieved via addition of 250 pL of buffer P2 
(Qiagen), gentle inversion, and incubation for 5 minutes. The solution was neutralized 
via addition of 350 pL of N3 buffer, mixed by inversion, and centrifuged for 10 minutes 
to pellet insoluble material. The supernatant was applied to the QIAprep spin column 
and centrifuged for 1 minute. The spin column was washed with 750 pL of PE buffer 
and centrifuged twice for 1 minute to remove excess ethanol. Plasmid DNA was eluted 
from the resin and into a microcentrifuge tube via centrifugation (12000 x g) after 
addition of 50 pL of 42°C ddH20  to the resin.
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Table 3. Plasmids used in this study
Plasmid Description0 Source or reference
pET28a(+) Vector for overexpression of His-tagged proteins 
using the T7 bacteriophage promoter
Novagen
pEV99 pET28a(+) derivative encoding the soluble 
portion of HtsA; KmR
(7, 58)
pLI50 E. coli/S. aureus shuttle vector; ApR CmR (84)
pEV55 pLI50 derivative containing htsABC from S. (7)
aureus; CmR
pAUL-A Temperature-sensitive S. aureus suicide vector; 
EmR Lcr
(17)
pUC19 E. coli cloning vector; ApR (153)
pJDC41 pET28a(+) derivative encoding SfaB; KmR (58)
pJDC42 pET28a(+) derivative encoding SfaD; KmR (58)
pDG1513
a a  i_ I . . .
pMTL22 derivative that carries a Tc resistance 
cassette; ApR
f t  A _ R  A„_R t -  _R _ J T  R _ ______________________ : _____
(59)
Abbreviations: KmR, ApR, CmR, EmR, and LcR, resistance to kanamycin, ampicillin, chloramphenicol, 
erythromycin, and lincomycin, respectively.
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2.2.2. Plasmid isolation from S. aureus
Plasmid DNA was isolated from S. aureus as described for E. coli, but with the 
following modifications. Approximately 1 mL of stationary phase S. aureus culture was 
harvested by centrifugation (10 000 x g) and resuspended in 250 pL of PI buffer that 
was modified by the addition of 50 pg mL'1 lysostaphin (Sigma). Cells were then 
incubated at 37°C for 30 minutes prior to addition of P2 buffer.
2.2.3. Restriction enzyme digests
Restriction endonucleases were purchased from Roche Diagnostics or New 
England Biolabs (NEB) and reactions were completed according to the manufacturer’s 
instructions. Typically, reactions were completed in 20 pL and incubated for 1 hour at 
37°C. The resulting DNA fragments were then cleaned using the QIAquick PCR 
purification kit (QIAgen) according to the manufacturer’s instructions.
2.2.4. DNA ligations
T4 DNA ligase was purchased from Roche Diagnostics or NEB and reactions 
were completed according to the manufacturer’s instructions. Typically, reactions were 
completed in 20 pL, with a 3:1 insert to vector DNA ratio, and incubated overnight at 
4°C.
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2.2.5. Agarose gel electrophoresis
Agarose gel electrophoresis was used to separate, visualize, and quantify DNA 
fragments. Agarose gels consisted of 0.8% w/v agarose in TAE buffer (40 mM Tris- 
acetate, 1 mM EDTA), supplemented with 1 pL SYBR Safe DNA gel stain (Invitrogen). 
Prior to loading, DNA samples were mixed with loading buffer (5% v/v glycerol, 0.04% 
w/v bromophenol blue, 0.04% w/v xylene cyanol, 10 mM EDTA, pH 7.5) in a 5:1 DNA 
to buffer ratio, and 12 pL was loaded per well. The gels were run at 110 V for 20 
minutes and a 1 kb-Plus ladder (Invitrogen) was used as a standard reference for 
estimating DNA size. After electrophoresis, gels were placed on a ChemiDoc XRS unit 
and DNA was visualized using Quantity One software (Bio-Rad).
2.2.6. In-well cell-lysis plasmid screening
In-well cell-lysis was used to rapidly screen E. coli for the presence of 
recombinant plasmid DNA. In summary, a 0.8% w/v TBE-agarose gel was 
supplemented with 0.4% w/v SDS prior to solidification and immersion in TBE buffer. 
A toothpick was then used to harvest a small quantity of E. coli cells from an agar plate 
that were resuspended in 10 pL of sterile water and 10 pL of SRL buffer (1 mg mL 1 
lysozyme, 25% w/v sucrose in TBE, and 10 pgmL"1 RNase A). Ten microlitres of each 
suspension was then loaded per well and allowed to incubated for 10 minutes at room 
temperature or until lysis was complete. The gels were then run at 20 V for 20 minutes, 
followed by 105 V for 30 minutes. The gels were then stained with ethidium bromide
(EtBr) and placed on a ChemiDoc XRS unit and DNA was visualized using Quantity 
One software (Bio-Rad).
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2.2.7. Isolation of DNA fragments from agarose gels
Following electrophoresis, desired DNA fragments were visualized and 
identified under UV light (365 nm) and excised from agarose gels using a glass cover 
slip. The DNA fragments were then isolated using the QIAquick Gel Extraction Kit 
(Qiagen), according to manufacturer’s instructions.
2.2.8. Isolation of chromosomal DNA from S. aureus
S', aureus Newman chromosomal DNA was obtained using the InstaGene Matrix 
(Bio-Rad) as described by the manufacturer. Typically, 1 pL of the resulting 
chromosome supernatant was used as template DNA in polymerase-chain reactions 
(PCR).
2.2.9. Polymerase-chain reaction
PCRs were completed in 50 pL reactions containing template DNA, lx PCR 
buffer (Roche Diagnostics), 200 pM dNTP (Roche Diagnostics), 12 picomoles of 
forward and reverse primers (IDT DNA), and 2.5 units of Pwol DNA polymerase 
(Roche diagnostics). PCRs were performed using the GeneAmp PCR system (Perkin- 
Elmer), the PTC-200 Peltier Thermal Cycler (MJ Research Inc.), or the MJ Mini™ 
Personal Thermal Cycler (Bio-Rad). Oligonucleotide primers are listed in Table 4.
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Table 4. Oligonucleotides used in this study
Purpose Sequence"
Cloning of htsA 
(Soluble Portion) 
Cloning of htsA 
(Soluble Portion) 
Cloning of htsABC 
(from S. aureus) 
Cloning of htsABC 
(from S. aureus) 
Cloning of sfaB 
(from S. aureus) 
Cloning of sfaB 
(from S. aureus) 
Cloning of sfaD 
(from S. aureus) 
Cloning of sfaD 
(from S. aureus)
5 ’ - AAGCT AGC ACT ATTT CGGT A A A AG AT G A A A AT G-3 ’ 
(forward, Nhel)
5 ’ - AAGG AT CCC ATTT ACTTCC ACCTT ACTTTT GTT C-3 ’ 
(reverse, BamHT) —
5 ’ -T G AGCT CT GCG ATT AC ATT GG AGGCT G-3 ’
(forward, Sacl)
5 ’ -TGCCCGGGGTT AGTT ATTT C ATT CTTCG-3 ’
(reverse, Smal)
5 ’ -T AAGCT AGC AT GGT AT AT CTT G AAT GGGC-3 ’ 
(forward, Nhel)




5 ’ -TCT GG AT CCTT AATT ATTTTCTCG AT AC AAAG-3 ’ 
(reverse, BamHT)
° Restriction sites for cloning of PCR products are underlined.
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2.2.10. Site-directed mutagenesis
Site-directed mutagenesis was carried out using the QuickChange® site-directed 
mutagenesis kit (Stratagene), using Pfu Turbo® DNA polymerase, or Phusion® DNA 
polymerase (New England Biolabs). Following amplification, DNA was treated with 
Dpnl endonuclease (New England Biolabs) to degrade template DNA. Remaining DNA 
was vacuum-centrifuged to a volume of approximately 20 pL prior to transformation of 
E. coli DH5a CaCl2 competent cells and plating on selective media. Primers were 
ordered from IDT DNA and are listed in Table 5.
Table 5. Oligonucleotides used for site-directed mutagenesis_________________
Purpose____________________ Sequence"_____________________________________________
Mutation o f HtsA, R104A 5 ’-GATTATACTTCTGTAGGTACAGCTAAACAGCC-3 »
Mutation o f HtsA, R104A  
Mutation o f HtsA, E l 10A
Mutation o f HtsA, E l 10A
Mutation o f HtsA, R126A
(forward)
5 ’-CTTCTAAGTTTGGCTGTTTAGCTGTACCT-3’ (reverse) 
5 ’ -CC A A ACTT AGÇAG A A ATT AGT A A ATT A A A AC-3 ’ 
(forward)
5 ’-CCGGTTTT A ATTT ACTA ATTTCTGCT A AGTTT G-3 ’ 
(reverse)
5 ’-G ATTT A ATTATCGCTG ATAGCAGTGCAC AT-3 ’
Mutation o f HtsA, R126A
Mutation o f HtsA, K203A  
Mutation o f HtsA, K203A  
Mutation o f HtsA, H209A  
Mutation o f HtsA, H209A  
Mutation o f HtsA, Y239A
(forward)
5 ’-TATTAATACCTTTATGTGC ACTGCTATC AGC-3 ’ 
(reverse)
5 ’ -CTTCC AGC AGTAGTTGCTGÇAGCTG-3 ’ (forward)
5 ’-G ATGTGCT A AT AAACC AGCTGC AGCA-3 ’ (reverse) 
5’-GCTAAAGCTGGTTTATTAGCAGCTCCA-3 * (forward)
5 ’-GTCCAACATATGAATAGTTTGGAGÇTGCT-3’ (reverse) 
5 ’ -CG ATGTA AC A AA AGGTTTAAGTAA AGÇTTTG A-3 ’
Mutation o f HtsA, Y239A  
Mutation o f HtsA, E250A
(forward)
5 ’-AGTAAGGTCCTTTC AAAGÇTTTACTTAAACC-3 ’ 
(reverse)
5 ’-CTTACTTAC AATTAGACACTGÇAC ATTT AGC-3 ’
Mutation o f HtsA, E250A  
Mutation o f HtsA, R86K  
Mutation o f HtsA, R86K 
Mutation o f HtsA, R104K
Mutation o f HtsA, R104K  
Mutation o f HtsA, R126K  
Mutation o f HtsA, R126K
(forward)
5 ’-C AGCTAAATGTGCAGTGTCTAATTGTAAG-3 ’ (reverse) 
5’-GTCGATGATGGTAAGAAAAAAAAAATC-3’ (forward)
5 ’-CTCTAACTGGTTTAATGATTTTTTTTTTC-3’ (reverse)
5 ’-GATT AT ACTTCTGTAGGTACAAAAAAACAGCC-3 ’ 
(forward)
5’-CTTCTAAGTTTGGCTGTTTTTTTGTACCT-3’ (reverse)
5 ’-TCGCTG AT AGC AGT A AAC AT AAAGGT A-3 ’ (forward) 
5’CTTTATTAATACCTTTATGTlTACTGCTATCAGC-3’
Mutation o f HtsA, K203R 
Mutation o f HtsA, K203R
Mutation o f HtsA, H209Q 
Mutation o f HtsA, H209Q 
Mutation o f HtsA, Y239F
(reverse)
5 ’-CC AGC AGTAGTTGCTAGAGCTGGTT-3’ (forward)
5 ’ -G ATGTGCTAAT AAACC AGCTÇTAGC A ACT A-3 ’ 
(reverse)
5’-GCTAAAGCTGGTTTATTAGCACAACCA-3 ’ (forward)
5’-GTCCAACATATGAATAGTTTGG1TGTGCT-3 ’ (reverse) 
5 ’ CG AT GT A AC A A A AGGTTT A AGT A A ATTTTT G A-3 ’
(forward)
Mutation o f HtsA, Y239F 5 ’-AGT AAGGTCCTTTC AAAAATTTACTT AAACC-3 ’
(reverse)
Mutated bases are underlined.
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2.2.11. DNA sequencing
DNA sequencing was provided by the DNA Sequencing Facility of the Robarts 
Research Institute (London, Ontario) or the York Sequencing Facility (Toronto, Ontario).
2.2.12. Computer analysis
DNA sequence analysis, oligonucleotide primer design, and protein analysis 
were completed using Vector NTI Suite software package (Informax, Bethesda, MD). 
Data was analyzed using Microsoft Office Excel and graphs were generated using 
GraphPad Prism 4.0.
2.3. Transformation methodologies
2.3.1. Preparation of transformation competent E. coli
E. coli DH5a CaCl2 competent cells were prepared as follows: An overnight, 
stationary phase DH5a culture was normalized to an OD600 of 1, diluted 1:100 into 500 
mL of fresh LB, and grown to an ODeoo of approximately 0.5. The culture was then 
placed on ice for 30 min and cells were harvested by centrifugation at 5 000 x g. The 
cells were then resuspended in 100 mL of CaCl2 solution (100 mM CaCl2, 15% glycerol) 
and incubated on ice for 30 min. Cells were harvested again by centrifugation, 
resuspended in 4 mL of CaCl2 solution, and aliquots of 100 pL were stored at -80°C.
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2.3.2. Transformation of CaCh competent.#, coli
Purified plasmid DNA or ligation reactions were added to an aliquot of E. coli 
DH5a CaCb competent cells and kept on ice for 30 min. Cells were then subjected to 
heat shock treatment at 42°C for 2 min followed immediately by 2 min incubation on ice. 
The cells were resuspended in 900 pL of fresh LB, mixed by inversion, and incubated 
for 1 h at 37°C prior to plating on selective media and incubation overnight.
2.3.3. Preparation of transformation competent & aureus
Strains of S. aureus were made electro-competent as follows: An overnight, 
stationary phase culture of S. aureus was normalized to an ODeoo of 1, diluted 1:100 into 
400 mL of fresh TSB, and grown to an OD6 0 0  of approximately 0.4. The cells were then 
harvested by centrifugation at 5 000 x g and resuspended in an equal volume of 500 mM 
sucrose and incubated on ice for 30 min. The cells were then harvested by centrifugation 
and resuspended in 4 mL of 500 mM sucrose. The last step was reeated and aliquots of 
60 pL were stored at -80°C.
2.3.4. Transformation of electro-competent S. aureus
Purified plasmid DNA was added to an aliquot of electro-competent S. aureus 
cells and kept on ice for 30 min. Cells were then transferred to an ice-cold 
electroporation cuvette (2 mm, Bio-Rad) for electroporation. Electroporation was 
performed using a Bio-Rad Gene Pulser II with the following settings: 2.5 V, 200 mA, 
and 25 Q. Pulsed cells were then resuspended in 900 pL of fresh TSB, transferred to a
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sterile micro-centrifuge tube, and incubated for 1 h at 37°C prior to plating on selective 
media and incubation overnight.
2.4. Mutagenesis and DNA cloning methodologies
2.4.1. Mutagenesis of htsABC
The construction of a S. aureus Newman strain bearing an htsABC::Tc operon 
deletion has been previously described (7). For complementation, the htsABC locus and 
flanking promoter region was PCR amplified from S. aureus Newman chromosomal 
DNA and the 4.0-kb fragment was cloned into pLI50, generating pEV55 as illustrated in 
Figure 6. Oligonucleotide primers used are listed in Table 4.
2.5. Siderophore synthesis, purification, quantification
2.5.1. Staphyloferrin A synthesis
Using rSfaB and rSfaD, in vitro SA biosynthesis was carried out as previously 
described (27), with minor modifications. Briefly, reactions were completed in 500 pL 
containing 1 mM sodium-citrate, 1 mM D-omithine, 5 mM ATP, 0.5 mM MgCh, 50 
mM HEPES, 5 pM rSfaB, and rSfaD at pH 7.4, and incubated for 12 hours in the dark at
room temperature.
Figure 6. Physical maps of plasmids pEV99 and pEV55. For pEV99, a fragment 
containing the soluble potion of the htsA coding region was cloned into the pET28a(+) 
protein overexpression vector between the BamHl and NheI restriction sites. The 
plasmid also contains a pBR233 origin of replication that allows for replication in Gram­
negative bacteria, a la d  region that encodes for a Lac repressor protein. For pEV55, a 
fragment containing the upstream regulatory sequence and the htsABC operon was 
cloned into the E. coli/S. aureus shuttle vector, pLI50, between the S a d  and Smal 
restriction sites. The plasmid also contains an ApR marker (bla) for selection in E. coli 
and a CmR marker (cat) for selection in S. aureus. The plasmid also contains two origins 








2.5.2. Staphyloferrin A purification
Following incubation, SA was purified from reactions as described (58). Briefly, 
enzymes were removed via centrifugation in an Amicon® Ultra-0.5 10k filter column 
(Millipore) at 14 000 x g  for 15 minutes. The filtrate was supplemented with 3 mM 
FeCfi and centrifuged at 18 000 x g  to remove precipitate. Fifty microlitres of the 
resulting solution was injected onto a Waters xTerra C l8 reversed-phase 5-pm column 
(150 mm x 2.1 mm) on a Beckman System Gold HPLC equipped with a photodiode 
array detector. The samples were run at 0.2 mL/min using a step gradient as previously 
described (27), with minor modifications. In summary, solvent B was 10 mM 
tetrabutylammonium phosphate, pH 7.3, in HPLC grade water (Fisher), and solvent A 
was 100% acetonitrile (Fisher). The step gradient consisted of a 2 min hold at 85% B, a 
1 min ramp and 4 min hold at 72% B, a 1 min ramp and 3.5 min hold at 66% B, and a 1 
min ramp and 3 min hold at 20% B. Peaks were monitored at 340 nm and data were 
analyzed using the 32 Karat Software Version 8.0 system. The peak corresponding to 
Fe-SA eluted at 17 min and was collected using the Beckman SC 100 fraction collector, 
vacuum-centrifuged to dryness, and resuspended in deionized water.
2.5.3. Staphyloferrin A detection
The presence of SA following in vitro synthesis was confirmed using chrome 
azurol S (CAS) shuttle solution (133), as previously described (32). Briefly, dilutions of 
S A reactions were mixed with equal volumes of CAS shuttle solution and incubated for 
45 min in the dark at room temperature. SA presence was verified through determination
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of siderophore units by the following formula: [(A630 of control reaction (missing ATP) 
-  A630 of sample)/(A630 of control reaction)(inverse of dilution factor)] x 100%.
The presence of Fe-SA following ion-pair HPLC purification was confirmed 
using liquid chromatography/mass spectrometry (LC/MS) as previously described (27), 
with minor modifications. In summary, EDTA was added to Fe-SA samples to increase 
SA detection sensitivity in the LC-MS (97).
2.5.4. Staphyloferrin A quantification (AAS)
Atomic absorption spectroscopy was used to indirectly determine the 
concentration of Fe-SA by measuring the concentration of iron in the HPLC-purified Fe- 
SA samples as previously described (58). Briefly, Fe-SA samples were diluted in 1 M 
nitric acid and then drawn by an SPS 5 sample preparation system (autosampler) into a 
Varian AA240 atomic absorption spectrometer. An iron/manganese hollow cathode 
lamp was used to detect iron absorbance by emitting at 248.3 nm. Calibration standards 
were analyzed to generate a linear calibration curve. The curve was generated using 
known iron standards, diluted in 1 M nitric acid, from an atomic absorption spectrometer 
certified 1000 ppm ± 1% stock (Fisher) before the Fe-SA samples were analyzed.
2.6. S. aureus growth curves
Bacteria were cultured for 12 h in TMS broth followed by an additional 12 h in 
fresh TMS broth. Cells were washed three times with 0.9% w/v saline and diluted 1:100 
into 80% horse serum (Sigma-Aldrich) and 20% Chelex® 100 resin (Bio-Rad) treated 
TMS broth. For iron replete media, 50 pM FeCl3 was added. Cultures were grown with
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constant, medium amplitude shaking in a Bioscreen C machine (Growth Curves, USA) 
and OD was measured at 600 nm every 30 min.
2.7. Disk-diffusion growth assays
The ability of Fe-SA to promote the iron-restricted growth of S. aureus Newman 
AsirAAhtsABC harbouring plasmid-borne WT or mutant htsABC was determined using 
disk-diffusion assays as previously described (7), with minor modifications. In summary, 
S. aureus cells were inoculated into TMS agar containing 10 pM EDDHA to achieve 1 x 
104 cells mL'1. Desferrioxamine (50 pM) was used as a positive control for growth. Ten 
microlitres of S A or Desferrioxamine were added to sterile paper disks which were then 
placed onto the plates. Growth diameter was measured after 24 h at 37°C.
2.8. Protein methodologies
2.8.1. Protein purification
The SA synthetases, SfaB and SfaD, and the SA-receptor, HtsA, were purified 
for use in SA synthesis reactions and Fe-SA fluorescence titration experiments, 
respectively. A rHtsA overexpression vector constructed as described (7, 58) was used 
to express and purify rHtsA from E. coli ER2566 as previously described (7). Briefly, 
DNA encoding a portion of mature HtsA (residues 38-327), was PCR amplified from S. 
aureus Newman chromosomal DNA and the 1-kb fragment was cloned into pET28a(+), 
generating pEV99 as illustrated in Figure 6. The sfaB and sfaD coding regions were 
amplified from S. aureus Newman chromosomal DNA and cloned into pET28a(+) for 
over-expression in E. coli BL21(DE3) as previously described (58). In summary,
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cultures were grown in LB (Difco) supplemented with 30 qg/mL Km at 37°C. At an 
ODöoo of ~0.9 isopropyl 1-thio-ß-D-galactopyranoside (IPTG) (500 qM) was added and 
the culture was incubated for an additional 18 h at room temperature with shaking (180 
rpm).
Cells were harvested by centrifugation at 15 000 x g, resuspended in binding 
buffer (50 mM HEPES, 500 mM NaCl, 10 mM imidazole at pH 7.4), and passed three 
times through a French pressure cell at 1500 p.s.i. Cell lysate was centrifuged at 15 000 
x g  to remove unbroken cells and debris and the supernatant was centrifuged at 150 000 
x g  for 1 h to precipitate insoluble material. The soluble fraction was applied to a 1-mL 
His-Trap nickel affinity column (GE Healthcare) equilibrated with binding buffer (50 
mM HEPES, 150 mM NaCl, 10 mM Imidazole, pH 7.4), and His6-tagged proteins were 
eluted with a gradient of 0-80% elution buffer (50 mM HEPES, 150 mM NaCl, 500 mM 
Imidazole, pH 7.4). Proteins were then dialyzed into 50 mM HEPES, 150 mM NaCl, and 
10% glycerol, pH 7.4, at 4°C. Protein purity was confirmed using SDS-polyacrylamide 
gel electrophoresis (see the following section) and 100-pL aliquots were frozen at -80°C.
2.8.2. Protein quantification
Protein concentrations were determined using a Bradford protein assay or 
spectrophotometric A2 8 0  assay for experiments and reactions or CD measurements, 
respectively. Protein yields for rSfaB, rSfaD, and WT or mutant rHtsA were 6.8, 25, and 
-50 mg L '1, respectively.
2.8.3. SDS-polyacrylamide gel electrophoresis
Proteins, whole-cell lysates, or resuspended detergent pellets were diluted 3:1 
with a protein loading buffer (10% glycerol, 64 mM Tris, 2% SDS, 5% (3- 
mercaptoethanol, and 0.01% bromophenol blue, pH 6.8) and boiled for 10 min prior to 
SDS-polyacrylamide gel electrophoresis, following standard protocols (127). Briefly, 
SDS-polyacrylamide gels consisted of a 5% acrylamide (Bio-Rad) stacking gel, 12% 
acrylamide (Bio-Rad) resolving gel, and were run at 130 V for 1.5 h. Proteins were 
stained with Coomassie Brilliant Blue R-250 using standard procedures. Gels were then 
visualized under white light, scanned using a CanoScan LiDE 700F, and illustrated 
using Adobe Photoshop CS2.
2.9. Western blotting methodologies
2.9.1. S. aureus whole cell lysate preparation
S. aureus cells were grown overnight in TMS media, diluted into fresh TMS, and 
grown for an additional 12 h. The cells were then washed three times with 0.9% w/v 
saline, equilibrated to an ODeoo of 1.2, and 100 pL were harvested via centrifugation (10 
000 x g) for 1 min. The pellets were then resuspended in 100 pL digestion buffer (30% 
w/v raffmose, 50 mM Tris, 145 mM NaCl, 10 pM phenylmethylsulfonyl fluoride, 50 pg 
mL'1 lysostaphin (Sigma), “pinch” iodoacetamide, and 20 pg mL'1 DNAse, pH 7.5) and 
incubated for 45 minutes at 37°C or until lysis was achieved.
i
58
2.9.2. Detergent partitioning of membrane proteins
S. aureus cells were grown overnight in TMS media, diluted into fresh TMS, and 
grown overnight to late-log-phase. The cells were then harvested by centrifugation (10 
000 x g), washed three times with 0.9% w/v saline, and equilibrated to an OD600 of 1.0 
in PBS. The cells were then supplemented with 50 pg mL'1 lysostaphin, incubated at 
37°C for 15 min, and diluted with 900 pL of PBS. Detergent extraction and phase 
partitioning was completed as previously described (25). In summary, cells were 
sonicated twice on a Branson Digital Sonifier® (Branson Ultrasonics Corporation,
USA) fitted with a 3-mm-diameter probe, and cooled on ice. 10% v/v Triton X-l 14 in 
PBS was then added and each sample was incubated for 2 h at 4°C. Samples were then 
centrifuged (13 000 x g) at 4°C for 10 min to pellet insoluble debris. The supernatants 
were transferred to clean microcentrifuge tubes, incubated at 37°C for 30 min, and 
centrifuged (13 000 x g) for 10 min at room temperature to pellet the detergent phase. 
The aqueous phase was then removed and the detergent pellet was washed with 1 mL 
PBS at 4°C for 1 h, transferred to 37°C for 30 min, repelleted, and diluted 1:1 in 
deionized water for solubilization.
2.9.3. Generation of anti-HtsA antisera
Rabbit polyclonal antibodies recognizing rHtsA were generated by ProSci 
(Poway, CA) using custom anti-body production package 1 protocol.
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2.9.4. Western Blotting
Following SDS-polyacrylamide electrophoresis, proteins were transferred to a 
BioTrace™ NT nitrocellulose membrane (Pall Life Sciences) at 250 mA for 1 h. The 
membranes were then transferred to a clean container, 30 mL of blocking buffer (10% 
v/v horse serum (Sigma) and 10% w/v skim milk) was added, and they were incubated 
overnight at 4°C with gentle shaking. Blocking buffer was then removed, 25 mL of a 
primary antibody solution (1/5000 dilution of primary antisera, 5% v/v horse serum 
(Sigma), and 2.5% w/v skim milk) was added, and they were incubated for 2 h at 4°C 
with gentle shaking. The primary antibody solution was then removed and the 
membranes were washed three times in ~25 mL TBS buffer (20 mM Tris and 150 mM 
NaCl, pH 7.5) for 10 min. 25 mL of a secondary antibody solution (1/7500 1 mg mL'1 
anti-rabbit IgG (H&L) (GOAT) Antibody IRDye800® Conjugated (Rockland), 5% v/v 
horse serum (Sigma), and 2.5% w/v skim milk) was added, and they were incubated for 
1 h at 4°C with gentle shaking. The secondary antibody solution was then removed and 
the membranes were washed three times in ~25 mL of TBS buffer supplemented with 
0.05% Tween-20 for 10 min. Membranes were then scanned on a Odyssey Infrared 
Imager (Li-Cor) and visualized using Odyssey V3.0 software (Li-Cor).
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2.10. rHtsA-SA fluorescence spectroscopy
The rHtsA-SA dissociation constant (Kd) was determined using fluorescence 
spectroscopy as described (58). In summary, fluorescence titration experiments were 
performed at room temperature using 15 nM rHtsA in 50 mM HEPES, pH 7.4, in a 
Fluorolog-3 spectrofluorometer (ISA Instruments) across a Fe-SA range of 0.22 and 226 
nM. Excitation and emission slits were set at 2.1 and 6.3 nm, respectively, and the 
excitation and emission wavelengths were set at 280 and 334 nm, respectively. Rvalues 
and relevant parameters were calculated by fitting the fluorescence data to a one-site 
binding model accounting for ligand depletion and data were analyzed by nonlinear 
regression analysis using the solver tool add-in from Microsoft Office® Excel software 
as previously described (134, 135).
2.11. Circular dichroism
Proteins were dialysed into a solution of 10 mM sodium phosphate and 150 mM 
sodium fluoride, pH 7.4, and normalized to a concentration where the A280 was ~0.2. 
Circular dichroism (CD) measurements were obtained using a J-810 spectropolarimeter 
(Jasco) with the following settings: standard sensitivity, 260-190 nm measurement range, 
0.5 nm data pitch, continuous scanning, 10 nm/min scanning speed, 1 nm bandwidth, 
and 5 accumulations per sample. Measurements were completed in a 1mm quartz 
cuvette and data was analyzed using Microsoft Office Excel. The CD signal (6, in 
millidegrees) was converted to mean residue ellipticity (MRE) {[6\, in deg cm2/dmol) 
using the equation [d\ = d x MRE/10 y. C x i ,  where MRE = MW In, prior to graphing.
Chapter 3 - Results
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3.1. HtsA has a unique Fe-SA binding pocket
At the start of this project we had just obtained the holo-structure of Fe-SA- 
rHtsA as illustrated in Figure 5. rHtsA is a class III substrate binding protein and has in 
common the overall protein fold embodied by other members of this protein family. 
However, the structure informed us that it used a novel form of ligand entrapment (i.e. 
many positively charged residues) to bind Fe-SA (58). In order to investigate the Fe-SA- 
rHtsA binding specificity and affinity, and to meet the objectives as outlined above, I 
needed to prepare sufficient quantities of Fe-SA and rHtsA.
3.2. In vitro synthesis of staphyloferrin A
Near the beginning of my project, Cotton et al. demonstrated that SA could be 
synthesized in vitro using recombinant SfaB and SfaD synthetases, along with citric acid 
and D-omithine as substrates (27). This confirmed the SA biosynthesis pathway 
illustrated in Figure 3. For the purposes of my project goals, rSfaB and rSfaD were 
overexpressed and purified. The purity and integrity of the rSfaB (69.4 kDa) and rSfaD 
(78.2 kDa) is demonstrated in Figure 7. SA synthesis reactions were set up as described 
(27). The ion-pair HPLC chromatogram illustrated in Figure 8 demonstrated that only 
the complete reaction generated a peak that corresponds to Fe-SA (27). Furthermore, 
CAS shuttle solution (133) was used to quickly assess the iron-binding activity of SA 
and, in agreement with previous findings, only complete SA synthesis reactions tested 
positive with CAS shuttle solution (133) (i.e. omitting either enzyme or any reaction 
component resulted in no siderophore activity).
Figure 7. rSfaB, rSfaD, and rHtsA proteins were purified. Coomassie stained SDS- 
polyacrylamide gel showing purified his-tagged rSfaB, rSfaD, and rHtsA.
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Figure 8. Ion-pair HPLC analysis of in vitro staphyloferrin A production. Missing 
reaction components are indicated on each trace. Reactions were monitored at 340 nm 
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SA had to be further purified from the in vitro synthesis reactions for use in Fe- 
SA-rHtsA binding assays. In order to obtain purified Fe-SA, ion-pair HPLC was used to 
separate the in vitro SA synthesis reaction components, and the fractions containing the 
SA peak were collected (Fig. 9A). LC/MS of the collected fractions and in vitro 
synthesis reactions detected SA at an m/z =479 in both samples, consistent with previous 
studies (27, 58). As illustrated in Fig. 9B, collection of ion-pair HPLC SA fractions 
reduces the amount of reaction contaminants present. Eight reaction mixtures, set up as 
described in the Materials and Methods section, were run across the HPLC column, 
yielding 4 mL o f—120 pM Fe-SA (data not shown).
Figure 9. Fe-SA can be separated and purified from reaction components using ion-pair 
HPLC. A) Ion-pair HPLC trace showing the Fe-SA peak eluting at 17.5 min, ahead of 
reaction components, which elute at 20 min. B) LC/MS demonstrating that Fe-SA 
fractions are purified from other reaction components. C) LC/MS of unpurified Fe-SA 
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3.3. rHtsA has high affinity for Fe-SA
Previous studies demonstrated that rHtsA is soluble, stable, and expresses well in 
E. coli BL21(DE3) (7, 58). Furthermore, the holo-crystal structure demonstrated that 
rHtsA could bind Fe-SA out of concentrated culture supernatants (58). As described in 
the methods section, plasmid pEV99 was used to overexpress rHtsA in E. coli and the 
protein was purified. The purity and integrity of the rHtsA (35.2 kDa) is demonstrated in 
Figure 7.
Changes in the intrinsic fluorescence of rHtsA were measured following ligand 
(Fe-SA) titration to determine the Fe-SA-rHtsA binding affinity (58). Saturating 
concentrations of Fe-SA caused an average 52.5% reduction of rHtsA fluorescence 
emission. The Fe-SA-rHtsA Kd was in the low nM range (~1.0 +/-0.3 nM) however; the 
value could not be determined accurately because the concentration of rHtsA (15 nM) 
used was greater than the Kd (Fig. 10), resulting in ligand depletion. The specificity of 
rHtsA for Fe-SA was demonstrated by the fact that another staphylococcal a- 
hydroxycarboxylate siderophore, Fe-SB, synthesized and purified as previously 
described (7), did not quench the intrinsic fluorescence of rHtsA (data not shown).
Figure 10. Saturation curve of the binding of Fe-SA to HtsA. rHtsA was titrated with 
increasing concentrations (as determined by atomic absorption spectroscopy) of Fe-SA 
and intrinsic fluorescence knockdown is depicted here as percent saturation. The 
experimental data is represented as the solid line with diamonds and the theoretical data 
(predicted by non-linear regression, one-site binding model) is the dashed line. Inset 
represents an emphasis in the region of Fe-SA concentrations used to determine the 
dissociation constant. Data is the result of three independent experiments using different 
batches of HtsA and error bars represent standard deviation from the mean.
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3.4. Amino acid substitutions do not affect overall protein fold of rHtsA
The Fe-SA-rHtsA crystal structure identified several rHtsA residues that formed 
contacts with Fe-SA (Fig. 5C). As outlined in the objectives, one of my goals was to 
determine the significance of those residues for productive binding in vitro. To 
investigate the role of each residue found to interact with SA, site-directed mutagenesis 
on pEV99 was used to substitute each interacting residue with either alanine or an amino 
acid with more conserved properties. Using the same strategy described earlier, rHtsA 
mutant derivatives were overexpressed and purified from E. coli BL21(DE3). No 
problems with solubility, stability, or expression of any of the proteins used in this study 
were encountered. The purity and integrity of the proteins is demonstrated in Figure 11.
In order to confirm that any reductions of Fe-SA binding affinity caused by 
mutation of rHtsA were not indirectly due to decreased structural integrity, CD spectra 
of each rHtsA protein were measured and compared to WT rHtsA. All proteins had an 
a-helical emission profile characteristic of class III binding proteins and none of the 
mutations I constructed in rHtsA resulted in any significant difference in the CD spectra 
compared to WT protein (Fig. 12).
Figure 11. WT and mutant rHtsA proteins were purified. Coomassie stained SDS- 
polyacrylamide gel showing purified his-tagged WT and mutant rHtsA.
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Figure 12. Point mutations do not result in gross rHtsA conformational changes. 
Circular dichroism spectra of WT and mutant rHtsA proteins indicate a proper a-helical 
conformation. Spectra were analyzed across wavelengths of 260 to 190 run. MRE, mean 
residue ellipticity.
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WT —  K203R 
R86K — — H209A 
R104A — H209Q 
R104K —  Y239A 
E110A — -Y 2 3 9F  
R126A — E250A 
R126K —  E110/250A 
K203A
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3.5. HtsA R104A, R126A, and H209A have reduced Fe-SA-rHtsA binding affinity
Using the approach described earlier, the effect that each mutation had on the Fe- 
SA-rHtsA Kd was determined (Table 6). R104A and R126A mutations resulted in the 
greatest reductions of binding affinity, failing to reach saturating levels of rHtsA 
fluorescence quenching at all concentrations of SA tested (>1.3 pM). H209A also had a 
significantly reduced binding affinity, failing to saturate rHtsA fluorescence quenching 
at all concentrations of SA tested as well (>10 pM). However, upon addition of ~1.2 pM 
Fe-SA, the fluorescence emission of H209A was reduced 24.9%, whereas R104A and 
R126A were only reduced 8% and 13%, respectively. This suggests that the H209A 
rHtsA mutant binds SA with greater affinity than the R104A or R126A rHtsA mutants. 
Also, the R104K mutation resulted in a ~700-fold decrease in binding affinity.














K203R Fe-SA 5.07±1.11 nM
H209A Fe-SA DNBC
H209Q Fe-SA 2.01±0.23 nM
Y239A Fe-SA 2.36±0.11 nM
Y239F Fe-SA 2.60±0.02 nM
E250A Fe-SA 1.18±0.17 nM
E110/250A Fe-SA NDd
a Ligands are ferrated prior fluorescence titrations. 
b Values represent averages and ± denotes standard deviation, n=3. 
c DNB, does not bind; no fluorescence saturation when [siderophore] > 1 pM. 
J ND, not determined.
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3.6. HtsABC is required for Fe-SA uptake
Previously, Beasley et al. demonstrated that HtsABC is required for the transport 
of Fe-SA using two separate assays (7). Additionally, it was demonstrated that 
chromosomal deletion of htsABC in S. aureus Newman in the absence of Fe-SB uptake 
results in a drastic reduction of growth under iron-restricted conditions (7). Using similar 
strategies, one of my major objectives was to determine the significance of each HtsA 
residue identified earlier for productive transport in vivo.
In order to do this, I first needed a vector that could complement the S. aureus 
Newman A htsABC associated growth reduction. Importantly, Beasley et al. also 
demonstrated that growth could be rescued via complementation with pEV55, an E. 
colHS. aureus shuttle vector containing the S. aureus htsABC operon and promoter 
region (7). To investigate the role of each residue found to interact with SA in vivo, site- 
directed mutagenesis on pEV55 was used to substitute each interacting residue with 
either alanine or an amino acid with more conserved properties.
3.7. S. aureus expresses recombinant HtsABC
Although previous studies demonstrated that plasmid-borne HtsABC could 
complement S. aureus Newman A htsABC, I needed to confirm proper expression of the 
mutant derivatives of HtsA. In order to verify this, Western immunoblots against HtsA 
were completed in whole cell lysates of S. aureus Newman A htsABC harboring WT or 
mutant pEV55. As illustrated in Figure 13, all pEV55 constructs resulted in similar HtsA 
expression levels.

Figure 13. WT and mutant HtsA express well in S. aureus Newman. Western 
immunoblots using anti-HtsA antiserum were completed on whole-cell lysates of S. 
aureus Newman. WT and mutant derivatives express similar amounts of HtsA. No HtsA 
is detected in the S. aureus mutant carrying empty vector.
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3.8. S. aureus HtsA localizes to the extracellular membrane
HtsA is a class III substrate binding protein that is tethered to the extracellular 
face of the cytoplasmic membrane via N-terminal lipidation. There, it functions as the 
Fe-SA-receptor before docking to its cognate permeases, HtsBC. In order to confirm that 
any growth deficits caused by mutation of HtsA were not indirectly due to altered 
protein expression and/or localization, Western immunoblots against HtsA were 
completed in detergent extracted membrane fractions of S. aureus harboring WT or 
mutant pEV55. As illustrated in Figure 14, all pEV55 constructs resulted in expression 
of HtsA that was localized to the cytoplasmic membrane.
Figure 14. WT and mutant HtsA localize to the cell membrane of S. aureus Newman. 
Western immunoblots using anti-HtsA antiserum were completed on detergent extracted 
membrane fractions from S. aureus Newman. No HtsA is detected in the S. aureus 
mutant carrying empty vector.
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3.9. Substitution of HtsA R104A, R126A, or H209A reduces Fe-SA-dependant 
growth of S. aureus in iron-restricted liquid growth media
In order to determine the significance of each HtsA residue substitution for 
productive transport in vivo, I generated iron-restricted growth curves of S. aureus 
Newman AhtsABC harboring WT or mutant derivatives of pEV55. As illustrated in 
Figure 15, substitution of HtsA R104A or R126A resulted in drastic growth reductions 
and substitution of HtsA H209A severely delayed growth. Importantly, these results 
agree with the binding affinity data which indicated that HtsA with substitutions R104A, 
R126A and H209A had severe reduction in ligand binding. Interestingly, although HtsA 
R104K had a 700-fold higher Kd for Fe-SA than WT HtsA, S. aureus harbouring this 
HtsA mutation was not debilitated for SA-dependent growth. All growth deficits were 
rescued by the addition of 50 p,M F eC f, a growth condition that eliminates the 
requirement for Fe-SA for growth.
Figure 15. Identification of HtsA mutations that impair SA-dependant growth of S. 
aureus. S. aureus expressing HtsA R104A, R126A, or H209A are impaired for SA- 
dependent growth. Inset, growth of all strains is restored with the addition of 50 pM 
FeCfi, thus eliminating the requirement for Fe-SA iron for growth. Growth is in 80% 
horse serum (Sigma) and 20% Chelex®-treated TMS. Error bars represent standard 
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3.10. An alternate growth assay identifies that HtsA R86K, R104A, R126A, R126K, 
K203A, H209A, H209Q, Y239A, and E110/250A mutants are impaired for Fe-SA- 
dependent growth of S. aureus
Beasley et al. used disk diffusion assays, in addition to the liquid culture growth 
curves, to further demonstrate the role of HtsABC in Fe-SA uptake (7). I used this assay 
in an attempt to gain more insight into the role of HtsABC in SA-dependent growth. 
Thus, disk-diffusion assays were completed for S. aureus Newman AhtsABC harboring 
WT or mutant pEV55, using purified Fe-SA that was spotted onto the bacteria- 
containing media. As illustrated in Figure 16, substitution of either HtsA R104A or 
R126A completely abolished Fe-SA-dependant growth and substitution of HtsA H209A 
significantly reduced Fe-SA-dependant growth. However, as opposed to the liquid 
growth assay, this assay identified that substitution of HtsA R86K, R126K, K203A, 
H209Q, Y239A, and El 10/250A also significantly reduced Fe-SA-dependent growth. 
However, growth reductions associated with these additional residues were more 
moderate. Importantly, this trend agrees with the binding affinity data. As a control, I 
showed that no growth differences were observed when Fe-Desferal™ was used as the 
iron source, demonstrating that the growth reductions observed were specific for Fe-SA.
Figure 16. Plate disk-diffusion growth assay confirms HtsA mutations that impair SA- 
dependant growth of S. aureus. Growth promotion is measured as the diameter (mm) of 
growth around each disk. The dashed line indicates the diameter of each disk and a 
measurement of 6 mm indicates no growth. In panel A, Fe-SA is added as the sole iron 
source, whereas in panel B, Fe-Desferal™ is added as the sole iron source. Error bars 
represent standard deviation, n — 3. Statistical significance is determined for each mutant 
in comparison to WT. a P=<0.0001. b P=<0.001.c P=<0.05.
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Chapter 4 - Discussion
Bacterial pathogens must have the ability to scavenge host iron in order to 
establish and maintain productive infections. S. aureus is one of the most successful 
human pathogens, partly due to its enormous virulence factor repertoire and multiple 
host iron-scavenging systems. Indeed, studies have demonstrated that disruption of 
staphyloferrin B biosynthesis reduces S. aureus pathogenesis in a mouse model of 
infection (32). Two staphylococcal siderophore systems have been genetically and 
biologically characterized. The sfa and hts loci encode the SA biosynthesis machinery 
(27) and ABC-transporter (7), respectively, and the sbn and sir operons encode the SB 
biosynthesis machinery and ABC-transporter, respectively (32). Recently, our laboratory, 
along with collaborators, published crystal structures of Fe-SA-rHtsA and Fe-SB-rSirA 
(58, 57). HtsA was the first Gram-positive a-hydroxycarboxylate siderophore receptor 
crystal structure. Although both SA and SB are anionic a-hydroxycarboxylate 
siderophores, each receptor is specific for its cognate siderophore (58, 57). The hts 
system is present ubiquitously among the chromosomes of sequenced Staphylococci 
making it an ideal candidate for binding affinity and biological studies in order to 
establish a model system of staphylococcal siderophore uptake.
The sfa locus was identified via bioinformatics searches and consists of genes 
expressing two NIS synthetases, an exporter, and a PLP-dependant ornithine racemase 
(27). The gene cluster is Fur regulated and is responsible for the synthesis and secretion 
of SA (27). It is present in all sequenced Staphylococcal chromosomes, including 
clinically relevant CoNS (7). SA has been isolated from culture supernatants of S. hyicus 
and chemically characterized (80). More recently, the biosynthesis pathway of SA has
been elucidated and it has been synthesized in vitro using rSfaB and rSfaD. One of the 
first objectives of this study was to purify sufficient amounts of Fe-SA from in vitro 
synthesis reactions.
Using the ion-pair HPLC strategy previously described, I separated Fe-SA from 
reaction components and collected the fractions that corresponded to the Fe-SA peak 
(27). This further purified the Fe-SA, a necessary step for its use in binding affinity 
assays (58). Although CAS shuttle solution (133) has been used to normalize SA 
siderophore units, it cannot be used to quantify the ion-pair HPLC fractions because they 
were ferrated prior to injection onto the column (7). Therefore, I chose an indirect 
approach to quantify the Fe-SA by using AAS to measure the amount of iron bound to 
SA in the samples. With the known siderophore to iron binding ratio of 1:1,1 determined 
the amount of Fe-SA present (58). This yielded sufficient amounts of Fe-SA for use in 
experiments (~120 p,M).
The hts operon is located adjacent to the sfa locus and is also present in the 
chromosomes of all sequenced staphylococci (7). It encodes a lipoprotein receptor and 
two permeases that are necessary for Fe-SA transport (7). However, the hts operon was 
first implicated in heme uptake following the observation that transposon disruption of 
hts resulted in preferential uptake of transferrin Fe(III) over heme Fe(II) (137). This 
phenomenon may be explained by a dual role of heme and Fe-SA uptake by the HtsBC 
permeases (7). Indeed, Cuiv et al. demonstrated that a Sinorhizobium meliloti 2011 
permease is involved in heme and hydroxamate siderophore uptake (31). However, it is 
unlikely that Hts A functions as a heme binding protein, as the crystal structure of Fe-
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SA-rHtsA identifies Fe-SA in a highly positively charged binding pocket that is more 
suitable for an anionic siderophore than a hydrophobic heme molecule (58).
One of the first major objectives of this study was to determine the binding 
affinity of HtsA for Fe-SA. This information would allow better comparisons with 
related proteins, provide insight on the mechanism of ligand binding, and further clarify 
the role of HtsA in Fe-SA transport. Using the purified Fe-SA and rHtsA I determined 
the Kd value of Fe-SA-rHtsA to be in the low nM range (58). This was the first 
determination of the affinity between an a-hydroxycarboxylate siderophore and its 
receptor (58). The strength of the affinity was not surprising considering that rHtsA 
complexed and crystallized with Fe-SA when exposed to ferrated S. aureus culture 
supernatant (58). The number of ionic contact points that rHtsA makes with Fe-SA in 
combination with the envelopment of Fe-SA in the binding pocket likely explains the 
high affinity. Furthermore, the affinity of rSirA for Fe-SB, another a- 
hydroxycarboxylate siderophore-receptor complex, has recently been published and is 
within the same range (57). Both affinities are within the range of several Gram-negative 
bacteria outer membrane receptors for their respective ligands but they are significantly 
greater than the affinity of E. coli FhuD (Table 1). The high affinities of HtsA and Sir A 
for Fe-SA and Fe-SB, respectively, are likely due to the number and type of ionic 
interactions involved in siderophore co-ordination (58, 57). However, the significant 
difference in their affinities compared to FhuD is likely accounted for by their ligand 
repertoire. Indeed, whereas HtsA and SirA are specific for Fe-SA and Fe-SB, 
respectively (58, 57), FhuD binds a broad range of Fe-hydroxamate siderophores (122), 
and likely sacrifices affinity for broadened substrate specificity.
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Unique open and closed ligand-bound conformations allowed identification and 
characterization of a novel form of ligand entrapment for a class III binding protein (58). 
Many crystal structures of related proteins, such as BtuF (10, 78), TroA (86, 87), FhuD 
(24, 82), and ShuT (67) have similar structural folds but little, if any, conformational 
changes between apo and holo forms. Although FitE (136) and FeuA (112) both undergo 
larger hinged movements more reminiscent of HtsA, their conformational changes are 
characterized by rigid interdomain movement, whereas HtsA conformational changes 
occur in isolated regions of the C-terminal domain (58). In addition, the unique HtsA 
movements help occlude SA by shifting it deeper in the binding pocket, reducing solvent 
exposure, and facilitating additional contact points (58). Only SirA has been 
demonstrated to have similar C-terminal domain movements however, the 
conformational changes, siderophore orientation, and receptor residues involved in 
coordination are distinct and each receptor is specific for its cognate siderophore (58,
57).
One of the major objectives of this study was to identify and mutate what were 
thought at the outset to be HtsA residues critical for Fe-SA interaction. Analysis of the 
crystal structure identified many potential residues and I initially selected six amino 
acids that form H-bonds with Fe-SA, R86, R104, R126, K203, H209, and Y239, and two 
residues predicted to form salt-bridges that mediate docking with the permeases, HtsBC, 
El 10 and E250 (58). In Grigg, Cooper, et al., we aligned 41 homologous sequences of 
HtsA which showed that the residues selected were conserved to varying degrees, R86, 
22/41; R104, 37/41; R126, 36/41; H209, 30/41; Y239, 9/41; El 10, 39/41; and E250, 
38/41 (58). I created alanine amino acid substitutions of each residue as well as less
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drastic amino acid substitutions that aimed to conserve size, charge, or ring structure.
My studies focused on the contribution of each residue to productive SA binding or 
transport. Before assessing their roles I confirmed that all mutant rHtsA could be 
expressed, purified, and properly folded from E. coli. I also confirmed that they express 
properly in S. aureus and localize to the cellular membrane.
To assess each residue’s importance for Fe-SA binding, I determined the effect 
that each substitution had on the Fe-SA-rHtsA binding affinity. The four residue 
substitutions that had the most drastic reductions of binding affinity were HtsA R104A, 
R126A, R126K and H209A. Interestingly, R104, R126, and H209 are the only residues 
investigated that form contacts with Fe-SA in both open and closed conformations of 
HtsA. This highlights the importance of the initial contacts made in the open 
conformation for Fe-SA binding. The R104 and R126 residues are also the most highly 
conserved of the selected residues that form contacts with Fe-SA and their importance 
for binding likely explains their degree of conservation. Furthermore, réintroduction of a 
positive charge via R104K substitution rescued Fe-SA-rHtsA binding, whereas R126K 
substitution did not. Therefore, the charge on residue R104 is likely the most important 
factor for productive binding, but the charge and position of residue R126 are both 
important. Substitution of H209A also eliminated measureable Fe-SA-rHtsA binding. 
Interestingly, H209 is the third most conserved residue and substitution of H209Q re­
established the low nM binding affinity of Fe-SA-rHtsA. This likely indicates an atom 
capable of H-bonding (nitrogen in this case) is necessary and sufficient for binding at 
residue H209. As expected, substitution of HtsA E250A, that is located outside of the 
binding pocket and predicted to be involved in docking with HtsBC, did not change the
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Fe-SA-rHtsA binding affinity. More surprising however is that substitution of HtsA 
K203A and Y239A, which are both involved in H-bonding with Fe-SA in the closed 
conformation, did not affect the Fe-SA-rHtsA binding affinity. It was especially 
interesting that the HtsA Y239A substitution did not elicit a pronounced effect because it 
moved 12.1 A between the open and closed conformations before H-bonding and 
enveloping Fe-SA in the binding pocket. Taken together, these results may indicate that 
the contacts formed in the open conformation are the most important for binding, 
whereas the contacts formed in the closed conformation may have more important roles 
in the selectivity of HtsA.
Another major focus of this research was to determine the significance that each 
residue has on iron-restricted SA-dependant growth of S. aureus Newman. Interestingly, 
the impact each HtsA residue substitution had on growth under these conditions 
mirrored their effect observed on the Fe-SA-rHtsA binding affinity. Substitution of HtsA 
R104A or R126A severely reduced S. aureus Newman growth. The binding affinity data 
suggests that this was likely due to their inability to facilitate Fe-SA binding. However, 
the ~700-fold reduction in binding affinity observed following substitution of HtsA 
R126K did not confer a measureable growth defect. Two possible explanations may 
account for this finding. First, pEV55 is a multi-copy vector and the subsequent increase 
in HtsA expression may have compensated for the decreased binding affinity and 
secondly, an ~700 nM Kd is still within the affinity range observed for FhuD and 
therefore, may not sufficiently compromise Fe-SA-HtsA binding and transport. 
Substitution of HtsA H209A severely delayed but did not eliminate growth. It is possible 
that the reduction of growth was not as severe as seen for the substitutions of HtsA
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R104A or R126A because it was still able to bind Fe-SA sufficiently for transport. 
Although the K^s of HtsA R104A, R126A, and H209A were not determined, the titration 
of HtsA H209A with Fe-SA resulted and a greater reduction of the intrinsic fluorescence 
which may indicate better binding (data not shown). Together with the lack of a growth 
phenotype observed for the R126K substitution, substitution of HtsA H209A likely 
permits sufficient Fe-SA binding to promote growth once enough HtsA is expressed, 
explaining the delay. Unlike the Fe-SA-rHtsA binding affinity, substitution of HtsA 
El 10/250A was expected to prevent docking of HtsA to HtsBC and therefore, prevent 
transport of Fe-SA and growth under iron-restricted Fe-SA-dependant conditions. 
However, no growth phenotype for HtsA El 10/250A was observed. This will be 
examined in more detail below. Also, once again substitution of HtsA K203A or Y239A 
did not affect the proper function of HtsA, as there was no observable growth phenotype 
for either substitution. This further suggests that the additional Fe-SA-HtsA contacts 
formed in the closed conformation of HtsA have a more significant role in ligand 
specificity than for productive binding and transport. This will be addressed in more 
detail in the future directions section of this thesis.
Finally, the last focus of my research was to use a disk diffusion assay as 
previously described, to further examine the significance that each residue has on Fe- 
SA-dependent growth promotion of S. aureus Newman. Importantly, the HtsA residue 
substitutions resulted in the same trend observed for growth promotion as seen in the 
growth curves and Fe-SA-rHtsA binding affinities. However, the disk-diffusion growth 
assay appeared to be more sensitive than the liquid growth assay. A possible explanation 
for the assay’s increased sensitivity is the higher degree of iron restriction (7.5 pM
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EDDHA) used in the growth media. In addition to the HtsA substitutions identified in 
the previous experiments, the substitution of HtsA R86K, R126K, K203A, H209Q, 
Y239A, Y239F and El 10/250A, resulted in significantly reduced growth promotion, 
albeit to a lesser degree than substitution of HtsA R104A, R126A, and H209A. 
Interestingly, substitution of HtsA R104K did not result in a significant growth 
phenotype and substitution of HtsA R126K only resulted in a modest growth reduction 
that was comparable to the growth reductions observed following substitution of HtsA 
R86K, K203A, H209Q, Y239F and El 10/250A. These proteins did not result in 
decreased Fe-SA binding affinities however, this may be due to the reductions being too 
subtle to detect with the concentration of HtsA used in the fluorescence titrations. Lower 
protein concentrations may result in more accurate Kjs that reflect the same trend 
observed for the growth reductions.
Although the results concerning the substitution of some of the HtsA residues 
involved in Fe-SA binding were expected, two very surprising findings of this study was 
the ability of the El 10/250A mutant derivative to facilitate productive transport of Fe- 
SA and the ability of the Y239A mutant derivative to facilitate productive binding and 
transport of Fe-SA. This was surprising because HtsA El 10 and E250 are both highly 
conserved (39/41 and 38/41, respectively) based on alignment of homologous HtsA 
sequences, and modeling of HtsBC with the Fe-SA-rHtsA crystal structure predicted that 
they are involved in Glu-Arg salt-bridge formation between the receptor and membrane 
transporter (58). More importantly, similar salt-bridge formation and subsequent 
docking with their cognate ABC-transporter is necessary for productive transport in 
related proteins, including E. coli FecB (12) and S. aureus FhuD2 (134). However, my
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data suggest that the HtsBC permeases may be less reliant on those residues than FecB 
or FhuD2 for docking of receptor and permease, or simply that the levels of SA- 
dependent growth observed in my assays due to high levels of multicopy HtsABC 
overshadowed any defects due to absence of the salt-bridge formation. As mentioned 
earlier, the absence of an effect of substitution of HtsA Y239A on productive binding or 
transport was also peculiar. Analysis of the open and closed forms of the Fe-SA-rHtsA 
crystal structure revealed that Y239 traversed the binding pocket before H-bonding and 
securing Fe-SA in the binding pocket. Furthermore, Y239 moves 12.1 A, the furthest of 
any HtsA residue, and is part of an eight amino acid insertion that absent from all 
homologous sequences (58). My data suggest that HtsA Y239 does not have a major role 
in productive binding or transport of Fe-SA however, its role in the specificity of HtsA 
for Fe-SA warrants further investigation.
In summary, I have determined the first Kd of an a-hydroxycarboxylate 
siderophore and its receptor, developed a method of purifying and quantifying useful 
quantities of Fe-SA from in vitro synthesis reactions, and analyzed and confirmed the 
contribution of several amino acid residues identified from the Fe-SA-rHtsA crystal 
structure. My methods will allow Fe-SA to be readily available for use in future 
experiments and my results have clarified some of the conclusions drawn from analysis 
of the crystal structure. For example, substitution of HtsA R104A, R126A, and H209A 
confirmed the importance of the residues that bind Fe-SA in the open conformation but 
substitution of HtsA Y239A and El 10/250A demonstrated the importance of verifying 
conclusions drawn from analysis of a crystal structure or from comparison with 
homologous proteins. Additionally, determination of the Fe-SA-rHtsA A^has facilitated
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comparison of HtsA with related class III binding proteins and Gram-negative outer 
membrane receptor proteins.
Future Directions
My research has increased the understanding of S. aureus SA binding and 
transport, the first such study involving a receptor protein for a polycarboxylate 
siderophore. Moreover, through this work I have also provided tools (purified and 
quantified Fe-SA) that can be used to facilitate greater knowledge of the staphylococcal 
sfa-hts system, including the generation of additional sets of mutations in htsA and even 
htsBC. One of the most interesting avenues of research that remains to be studied is 
investigation of the importance of SA-mediated iron uptake in CoNS. There is no iron- 
restricted growth defect associated with the loss of sfa or hts in S. aureus, due to the 
presence of the s,6«-s,/>-encoded SB iron uptake system. However, this latter system is 
absent from all sequenced chromosomes of CoNS (7) and, therefore, in these organisms, 
the sfa-hts system may take on a more prominent role in iron acquisition and potentially 
virulence. Additionally, the contribution of HtsABC to heme uptake has yet to be 
resolved. Thorough analysis of htsA and htsBC mutants or the identification of an 
additional lipoprotein involved in heme uptake would clarify the role of the hts system 
in staphylococci and significantly improve our understanding of S. aureus host iron- 
uptake strategies. Also, because my results demonstrated the importance of verifying 
conclusions drawn from a crystal structure, further investigations into the roles of the 
residues that have been identified in the Fe-SB-rSirA crystal structure are warranted.
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